• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    贝

    贝尔维特大学医院

    Bellvitge University Hospital,Institut Català de la Salut,Government of Catalonia
    EST. 1972
    1.2万论文总数
    28.9万引用总数

    The Bellvitge University Hospital (in Catalan Hospital Universitari de Bellvitge), is a public hospital located in town of l'Hospitalet de Llobregat, with an outstanding care, teaching and researching activity. It is specialized in high complexity medical care. It offers all the medical specialties, except for pediatrics and obstetrics. It has been acknowledged five times (years 2004, 2006, 2009, 2010 and 2011) as one of the four best hospitals in Spain in its category by the independent evaluating agency Iasist.The hospital is served by the Hospital de Bellvitge metro station, on line L1 of the Barcelona Metro, which is located under the hospital car park..

    论文量&引用量时间轴

    机构学者

    论文(10000)

    年份
    起
    –
    止
    排序
    1Focal Upper Limb Peripheral Nerve Injury after Prone Positioning in Patients with ARDS: A Prospective Neurophysiological Cohort Study
    Filippo Binda,Federica Marelli,Veronica Rossi,Maurizio Vergari,Giada Aglieco, Martina Nigro,Maura Lusignani,Alessandro Galazzi, Gemma Via-Clavero,Oriol Roca,Giacomo Grasselli

    Objectives: To investigate the incidence, timing, and neurophysiological characteristics of focal upper limb peripheral nerve injury (PNI) related to positional brachial plexus involvement after prone positioning in patients with acute respiratory distress syndrome (ARDS). Methods: Prospective single-centre observational cohort study conducted in the ICU of an academic tertiary-level hospital in Milan (Italy), between April 2022 and September 2025. All adult patients with ARDS requiring invasive mechanical ventilation and treated with prone positioning were screened. Patients underwent predefined longitudinal neurophysiological assessments at baseline, after each prone positioning cycle and before ICU discharge, whenever feasible. Focal upper limb PNI was defined using specific electrodiagnostic criteria. Cumulative incidence analyses accounted for ICU death as a competing event. Results: Overall, 128 prone positioning cycles were performed in 54 patients. Focal upper limb PNI occurred in 11 patients (20.4%; 95% CI 10.6-33.5), after a median of 2 prone positioning cycles (IQR 1-3) and 36 h (IQR 21-50) of cumulative prone exposure. By day 28, the estimated cumulative incidence was 29.1% (95% CI 11.6-46.7), rising to 42.7% (95% CI 17.6-67.9) in patients exposed to at least one uninterrupted prone cycle lasting >= 24 h, compared with 8.6% (95% CI 0-20.4) in patients with shorter exposure (p = 0.047). Among prone positioningrelated complications, pressure ulcers were the most frequent, occurring in 40.7% (22/54) of patients and predominantly involving the facial region, whereas no vascular access loss or accidental endotracheal tube displacement were recorded. Conclusions: Focal upper limb PNI was a frequent, clinically relevant, and potentially under-recognised complication of prolonged prone positioning in patients with ARDS. Implications for clinical practice: A prone positioning bundle should include systematic upper limb surveillance, repeated reassessment of limb, head and shoulder alignment, and early detection of focal asymmetric upper limb weakness, particularly during uninterrupted prone cycles lasting 24 h or longer.

    2027INTENSIVE AND CRITICAL CARE NURSING(2027)
    引用
    AI阅读
    加入学术空间
    2Expert Consensus on Optimal Management of Liver-Related Adverse Events During CDK4/6 Inhibitor Therapy.
    Sonia Pernas, Xavier Forns,Olga Martínez-Sáez,Raúl Andrade,Alberto Amador,Elena López-Miranda,Begoña Bermejo, Beatriz Mateos, Monica Cejuela, María José Villanueva, Patricia Palacios Ozores,Mar Riveiro-Barciela,

    Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR + /HER2 −) breast cancer (BC) is the most frequently diagnosed subtype of BC, accounting for approximately 70

    2026Clinical and Translational Oncology(2026)引用:52
    引用
    AI阅读
    加入学术空间
    3New Genetic Feature Associated with Fundus Albipunctatus: Case Series of Two Spanish Children with LRAT Gene Mutation.
    Anna Baldaquí-Baeza, Jesús Díaz-Cascajosa, Delia Yubero-Siles, Gema Escribano-Serrano, Diana Salinas-Chaparro, Cinthia Aguilera, Anna Esteve-Garcia, Itziar Alonso-Colmenero, Jaume Català-Mora

    To describe the genetic mutation and its action mechanism in patients with compatible diagnosis of fundus albipunctatus (FAP). We describe the clinical evolution and genetic findings of two female Spanish children of 14 and 16 years old who have been followed at the children’s hospital Sant Joan de Déu (Barcelona, Spain). Nyctalopia without detectable field constriction was the initial symptom. Retinal fundus was compatible with FAP or retinitis punctata albescens (RPA). We have registered ophthalmological examination from each visit, including visual acuity, visual field assessment, wide-field fundoscopy imaging, fundus autofluorescence and optical coherence tomography. Full-field electroretinogram (ERG) was also performed. DNA sampling was analysed by next-generation sequency (NGS). Compound heterozygous pathogenic variants in the LRAT gene were identified in both children. Interestingly, these were the same two pathogenic variants, despite the families being unrelated. No additional genetic alterations were found that could explain the disease in our patients. To the best of our knowledge, up to the present time, only a single clinical case involving a genetic variant in the LRAT gene leading to an FAP phenotype has been reported in the literature. LRAT genetic variants, despite their low frequency in clinical practice, seem to lead to a FAP-like phenotype, in addition to their established association with Leber congenital amaurosis (LCA) and Early Onset Severe Retinal Dystrophy (EOSRD).

    2026Documenta Ophthalmologica(2026)引用:15
    引用
    AI阅读
    加入学术空间
    4Mechanical Thrombectomy Failure in Anterior Circulation Large Vessel Occlusion: an Overview from the ROSSETTI Registry.
    Lluis Morales-Caba, Josep Puig, Juan Manuel Sanchís, Víctor Vázquez,Mariano Werner, Guillem Dolz, Marc Comas-Cufí, Pepus Daunis-I-Estadella,Pedro Vega,Eduardo Murias,Eva González, Xabier Manso,

    BACKGROUND:Although mechanical thrombectomy (MT) is an effective treatment for large vessel occlusion (LVO) with a high successful recanalization rate, MT failure (MTF) occurs in 10-15% of cases and is associated with unfavorable outcomes. However, little is known about the clinical, technical, and radiological reasons for MTF. We investigated the technical factors associated with MTF. METHODS:We conducted a retrospective analysis of consecutive patients with anterior LVO prospectively included in the ongoing observational multicenter ROSSETTI registry. Patients were categorized according to the success (≥mTICI 2b) or failure (<mTICI 2b) of the MT procedure. Baseline clinical and demographic characteristics, endovascular MT techniques, and angiographic and clinical outcomes were compared. Multivariate analysis for prediction of MTF was performed. RESULTS:We analyzed 4135 patients, including 325 patients (7.9%) with MTF. Patients in the MTF group had a significantly lower Alberta Stroke Program Early CT Score (ASPECTS) at baseline (8 (7-10) vs 9 (8-10)), longer time since last time seen well (279 min vs 262 min), increased MT procedure time (76 min vs 31 min), higher rate of complications (23% vs 4%), higher symptomatic intracerebral hemorrhage (21% vs 7.9%), higher 24 hour National Institutes of Health Stroke Scale score (19 vs 6), worse functional outcome at 3 months (modified Rankin Scale score 0-2, 15.6% vs 53%), and higher mortality (45% vs 20%). Four or more passes were an independent predictor of MTF (OR 3.46, 95% CI 2.58 to 4.63; P<0.001). None of the endovascular techniques demonstrated a higher likelihood of MTF. CONCLUSION:In this study, MTF in anterior circulation LVO was associated with a high complication rate and worse outcomes.

    2026Journal of neurointerventional surgery(2026)引用:3
    引用
    AI阅读
    加入学术空间
    5Long-term Benefits of Upadacitinib for Atopic Dermatitis: Deep Responses in Patient-Reported Outcomes over 140 Weeks from the Measure Up 1 and Measure Up 2 Clinical Trials
    Eric L Simpson,Vimal H Prajapati,Christopher G Bunick,Raj Chovatiya, Linda F Stein Gold,Ignasi Figueras Nart, Brian Calimlim,Ayman Grada, Alena Pechonkina, Chao Li, Bang Truong, Xiaofei Hu,

    Objectives Atopic dermatitis (AD), a chronic, immune-mediated inflammatory disease, is characterized by intense itch, eczematous rash, and skin pain, which can have negative impacts to quality-of-life (QoL), sleep, and mental health (especially anxiety and depression). Evaluation of the impacts of AD on the patient’s lived experience are most accurately assessed by the patient, making measures of patient-reported outcomes (PROs) indispensable. The objective of the current study was to assess the long-term impact of upadacitinib, a once-daily oral selective Janus kinase inhibitor approved for the treatment of moderate-to-severe AD, on patient-reported outcomes, providing a comprehensive in-depth evaluation of results of patient experience across multiple domains.Methods Using integrated data from the Measure Up 1 & 2 trials, the current study characterizes the efficacy of upadacitinib on several measures that assess the impact of AD on patients’ lives, including patient-reported disease and symptom severity, sleep, emotional well-being, daily activities, QoL, and treatment satisfaction.Results Results demonstrated that rapid improvements in PRO measures of itch, sleep, daily activities, QoL, and emotional well-being reported at week 16 and week 52 were sustained or further improved at week 140 for patients with moderate-to-severe AD continuing upadacitinib 15 mg or 30 mg therapy, with no new safety signals observed.Conclusions These findings support upadacitinib as a long-term treatment option to improve patient-reported burdensome symptoms of AD across 140 weeks of exposure.

    2026The Journal of dermatological treatment(2026)引用:2
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 10000 篇论文

    合作机构(100)

    巴塞罗那大学合作论文 1,180
    瓦尔德希布伦大学医院合作论文 812
    巴塞罗那医院合作论文 781
    Hospital de Sant Pau合作论文 676
    格雷戈里奥·马拉尼翁综合大学医院合作论文 553
    Hospital Universitario La Paz合作论文 536
    巴塞罗那自治大学合作论文 528
    Marqués de Valdecilla 大学医院合作论文 473
    Hospital Universitario Ramón y Cajal,Comunidad de Madrid合作论文 424
    Central University Hospital of Asturias合作论文 416

    机构统计